Opportunities for pharmacists in dermatology
There is now an interest group for specialist dermatology pharmacists and work is in progress with British Association of Dermatologists to develop suitable training. As Kläre Bryant, advanced… read more.
There is now an interest group for specialist dermatology pharmacists and work is in progress with British Association of Dermatologists to develop suitable training. As Kläre Bryant, advanced… read more.
Kläre Bryant, advanced clinical pharmacist in dermatology at Liverpool University Hospitals, was a recently-qualified independent prescriber when she managed the switch to biosimilar infliximab for the cohort of… read more.
Feedback from a satisfied patient illustrates the impact that good pharmaceutical care can have on dermatological disease, according to Kläre Bryant, advanced clinical pharmacist in dermatology at Liverpool… read more.
Kläre Bryant is an advanced clinical pharmacist who has been holding clinics for dermatology patients receiving biologics and other systemic treatments for more than nine years. IMI spoke… read more.
A key ingredient is missing from all sunscreens and anti-aging creams, and our skin will be far better protected from the damaging effects of the sun once this… read more.
LEO Pharma announced up to 3.5-year data that further support the long-term safety and efficacy profile of Adbry (tralokinumab-ldrm) in adult patients with moderate-to-severe atopic dermatitis (AD). The… read more.
A report of nine cases of alopecia areata (AA) following SARS-CoV-2 vaccination appears to confirm suspicions that mRNA vaccines can trigger autoimmune responses that lead to hair loss…. read more.
AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus… read more.
Patients treated for Merkel cell carcinoma (MCC) face a five-year recurrence rate of 40% — markedly higher than the recurrence rates for cand other skin cancers, according to… read more.
Acne on the face is often treated with topical antibiotics, which tend to be used for an extended period of time and contribute to the serious problem of… read more.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced comprehensive efficacy and safety data from the DISCOVER–2 trial of Tremfya (guselkumab) were published in Arthritis & Rheumatology, representing… read more.
Research by the Oregon State University College of Pharmacy suggests that a vaccine stimulating production of a protein critical to the skin’s antioxidant network could help people bolster… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.